Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Xiaolin Zhang
Person

Xiaolin Zhang

Tracked across 1 events · 6 articles · First seen May 31, 2026 · Last active May 31, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 60
Tech
Dizal Presents Positive NSCLC Data
Dizal Pharmaceutical announced positive results from two studies in non-small cell lung cancer (NSCLC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The first study showcased DZD6008, a fourth-generation EGFR TKI, demonstrating…
Impact: As CEO of Dizal Pharmaceutical, Dr. Xiaolin Zhang's statements highlight the significance of the clinical data and the company's commitment to addressing unmet medical needs.
May 31, 2026 · 6 articles
NEWSDESK
Track Xiaolin Zhang live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.